Niagen Bioscience (NAGE) Inventory Average (2011 - 2026)
Niagen Bioscience (NAGE) posted quarterly Inventory Average of $22.2 million for Q1 2026, up 118.09% year-over-year from $10.2 million in Q1 2025, and up 13.32% quarter-over-quarter from $19.6 million in Q4 2025.
Niagen Bioscience (NAGE) Inventory Average (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has reported Inventory Average for 14 consecutive years, with $22.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 118.09% year-over-year to $22.2 million; the TTM figure through Mar 2026 stood at $22.2 million (up 118.09% YoY), while the FY2025 annual figure was $14.8 million, up 24.87% from the prior year.
- Inventory Average improved to $22.2 million in Q1 2026 per NAGE's latest filing, from $19.6 million in the prior quarter.
- Across five years, Inventory Average topped out at $22.2 million in Q1 2026 and bottomed at $9.9 million in Q4 2024.
- Historically, Inventory Average has averaged $14.1 million across 5 years, with a median of $13.5 million in 2024.
- Annual changes were most pronounced in 2024 — Inventory Average slipped 27.3% — and 2026, when it surged 118.09%.
- Niagen Bioscience's Inventory Average stood at $15.2 million in 2022, then slipped by 10.44% to $13.6 million in 2023, then retreated by 27.3% to $9.9 million in 2024, then soared by 98.7% to $19.6 million in 2025, then rose by 13.32% to $22.2 million in 2026.
- Business Quant data shows NAGE's Inventory Average at $22.2 million in Q1 2026, $19.6 million in Q4 2025, and $16.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Niagen Bioscience | 238.30 Mn | 171.56 Mn | 19.31 Mn | 22.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.33 Mn |
| Mar 31, 2026 | 22.22 Mn |
| Dec 31, 2025 | 19.61 Mn |
| Sep 30, 2025 | 16.60 Mn |
| Jun 30, 2025 | 12.80 Mn |
| Mar 31, 2025 | 10.19 Mn |
| Dec 31, 2024 | 9.87 Mn |
| Sep 30, 2024 | 11.03 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 13.51 Mn |
| Dec 31, 2023 | 13.57 Mn |
| Sep 30, 2023 | 12.30 Mn |
| Jun 30, 2023 | 11.94 Mn |
| Mar 31, 2023 | 13.29 Mn |
| Dec 31, 2022 | 15.16 Mn |
| Sep 30, 2022 | 15.69 Mn |
| Jun 30, 2022 | 15.53 Mn |
| Mar 31, 2022 | 14.45 Mn |
| Dec 31, 2021 | 13.14 Mn |
| Sep 30, 2021 | 12.43 Mn |